Fibrolamellar hepatocellular carcinoma responsive to platinum-based combination chemotherapy.
作者信息
Bower M, Newlands E S, Habib N
机构信息
Charing Cross Hospital, London, UK.
出版信息
Clin Oncol (R Coll Radiol). 1996;8(5):331-3. doi: 10.1016/s0936-6555(05)80724-1.
PMID:8934055
Abstract
A patient with advanced unresectable fibrolamellar hepatocellular carcinoma is reported, who was treated with cisplatinum, epirubicin and 5-fluorouracil combination chemotherapy. Tumour regression was achieved, enabling major debulking surgery to be performed. The patient remains in clinical remission 11 months after completing therapy.
摘要
Zotero 插件